PPARgamma Pro12Ala Pro/Pro and resistin SNP-420 G/G genotypes are synergistically associated with plasma resistin in the Japanese general population
The Ala allele of the Pro12Ala polymorphism (rs1801282) of peroxisome proliferator-activated receptor gamma (PPARgamma) is protective against type 2 diabetes (T2DM). Resistin, secreted from adipocytes, causes insulin resistance in rodents. Resistin gene expression is reduced by the PPARgamma ligand....
Saved in:
Published in | Clinical endocrinology (Oxford) Vol. 71; no. 3; p. 341 |
---|---|
Main Authors | , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
01.09.2009
|
Subjects | |
Online Access | Get full text |
ISSN | 1365-2265 1365-2265 |
DOI | 10.1111/j.1365-2265.2008.03465.x |
Cover
Abstract | The Ala allele of the Pro12Ala polymorphism (rs1801282) of peroxisome proliferator-activated receptor gamma (PPARgamma) is protective against type 2 diabetes (T2DM). Resistin, secreted from adipocytes, causes insulin resistance in rodents. Resistin gene expression is reduced by the PPARgamma ligand. We previously reported that subjects with the G/G genotype of a resistin gene single nucleotide polymorphism (SNP) at -420 (rs1862513) had the highest circulating resistin levels, followed by C/G and C/C. The aim of this study was to determine the relationship among PPARgamma Pro12Ala polymorphism, resistin SNP-420, and plasma resistin.
We cross-sectionally analysed 2077 community-dwelling subjects attending an annual medical check-up. Genotypes were determined by TaqMan analysis. Fasting plasma resistin was measured using ELISA.
Plasma resistin appeared to be higher in subjects with the Pro/Pro genotype of PPARgamma than those with Pro/Ala and Ala/Ala genotypes (mean +/- SE, 11.6 +/- 0.2 vs. 10.4 +/- 0.5 microg/l). Multiple regression analysis, adjusted for age, gender, BMI, and resistin SNP-420, revealed that the Pro/Pro genotype was a positive predictor of plasma resistin (PPARgamma , Pro/Pro vs. Pro/Ala + Ala/Ala, unstandardized regression coefficient (beta) = 1.03, P = 0.0384). The effects of the Pro/Pro genotype of PPARgamma (Pro/Pro vs. Pro/Ala + Ala/Ala) and the G/G genotype of resistin SNP-420 (G/G vs. C/C) on plasma resistin were synergistic (beta = 4.76, P = 0.011).
The PPARgamma Pro12Ala Pro/Pro and resistin SNP-420 G/G genotypes were synergistically associated with plasma resistin, when adjusted for age, gender, and BMI, in the Japanese general population. |
---|---|
AbstractList | The Ala allele of the Pro12Ala polymorphism (rs1801282) of peroxisome proliferator-activated receptor gamma (PPARgamma) is protective against type 2 diabetes (T2DM). Resistin, secreted from adipocytes, causes insulin resistance in rodents. Resistin gene expression is reduced by the PPARgamma ligand. We previously reported that subjects with the G/G genotype of a resistin gene single nucleotide polymorphism (SNP) at -420 (rs1862513) had the highest circulating resistin levels, followed by C/G and C/C. The aim of this study was to determine the relationship among PPARgamma Pro12Ala polymorphism, resistin SNP-420, and plasma resistin.OBJECTIVEThe Ala allele of the Pro12Ala polymorphism (rs1801282) of peroxisome proliferator-activated receptor gamma (PPARgamma) is protective against type 2 diabetes (T2DM). Resistin, secreted from adipocytes, causes insulin resistance in rodents. Resistin gene expression is reduced by the PPARgamma ligand. We previously reported that subjects with the G/G genotype of a resistin gene single nucleotide polymorphism (SNP) at -420 (rs1862513) had the highest circulating resistin levels, followed by C/G and C/C. The aim of this study was to determine the relationship among PPARgamma Pro12Ala polymorphism, resistin SNP-420, and plasma resistin.We cross-sectionally analysed 2077 community-dwelling subjects attending an annual medical check-up. Genotypes were determined by TaqMan analysis. Fasting plasma resistin was measured using ELISA.DESIGN, PATIENTS AND MEASUREMENTSWe cross-sectionally analysed 2077 community-dwelling subjects attending an annual medical check-up. Genotypes were determined by TaqMan analysis. Fasting plasma resistin was measured using ELISA.Plasma resistin appeared to be higher in subjects with the Pro/Pro genotype of PPARgamma than those with Pro/Ala and Ala/Ala genotypes (mean +/- SE, 11.6 +/- 0.2 vs. 10.4 +/- 0.5 microg/l). Multiple regression analysis, adjusted for age, gender, BMI, and resistin SNP-420, revealed that the Pro/Pro genotype was a positive predictor of plasma resistin (PPARgamma , Pro/Pro vs. Pro/Ala + Ala/Ala, unstandardized regression coefficient (beta) = 1.03, P = 0.0384). The effects of the Pro/Pro genotype of PPARgamma (Pro/Pro vs. Pro/Ala + Ala/Ala) and the G/G genotype of resistin SNP-420 (G/G vs. C/C) on plasma resistin were synergistic (beta = 4.76, P = 0.011).RESULTSPlasma resistin appeared to be higher in subjects with the Pro/Pro genotype of PPARgamma than those with Pro/Ala and Ala/Ala genotypes (mean +/- SE, 11.6 +/- 0.2 vs. 10.4 +/- 0.5 microg/l). Multiple regression analysis, adjusted for age, gender, BMI, and resistin SNP-420, revealed that the Pro/Pro genotype was a positive predictor of plasma resistin (PPARgamma , Pro/Pro vs. Pro/Ala + Ala/Ala, unstandardized regression coefficient (beta) = 1.03, P = 0.0384). The effects of the Pro/Pro genotype of PPARgamma (Pro/Pro vs. Pro/Ala + Ala/Ala) and the G/G genotype of resistin SNP-420 (G/G vs. C/C) on plasma resistin were synergistic (beta = 4.76, P = 0.011).The PPARgamma Pro12Ala Pro/Pro and resistin SNP-420 G/G genotypes were synergistically associated with plasma resistin, when adjusted for age, gender, and BMI, in the Japanese general population.CONCLUSIONSThe PPARgamma Pro12Ala Pro/Pro and resistin SNP-420 G/G genotypes were synergistically associated with plasma resistin, when adjusted for age, gender, and BMI, in the Japanese general population. The Ala allele of the Pro12Ala polymorphism (rs1801282) of peroxisome proliferator-activated receptor gamma (PPARgamma) is protective against type 2 diabetes (T2DM). Resistin, secreted from adipocytes, causes insulin resistance in rodents. Resistin gene expression is reduced by the PPARgamma ligand. We previously reported that subjects with the G/G genotype of a resistin gene single nucleotide polymorphism (SNP) at -420 (rs1862513) had the highest circulating resistin levels, followed by C/G and C/C. The aim of this study was to determine the relationship among PPARgamma Pro12Ala polymorphism, resistin SNP-420, and plasma resistin. We cross-sectionally analysed 2077 community-dwelling subjects attending an annual medical check-up. Genotypes were determined by TaqMan analysis. Fasting plasma resistin was measured using ELISA. Plasma resistin appeared to be higher in subjects with the Pro/Pro genotype of PPARgamma than those with Pro/Ala and Ala/Ala genotypes (mean +/- SE, 11.6 +/- 0.2 vs. 10.4 +/- 0.5 microg/l). Multiple regression analysis, adjusted for age, gender, BMI, and resistin SNP-420, revealed that the Pro/Pro genotype was a positive predictor of plasma resistin (PPARgamma , Pro/Pro vs. Pro/Ala + Ala/Ala, unstandardized regression coefficient (beta) = 1.03, P = 0.0384). The effects of the Pro/Pro genotype of PPARgamma (Pro/Pro vs. Pro/Ala + Ala/Ala) and the G/G genotype of resistin SNP-420 (G/G vs. C/C) on plasma resistin were synergistic (beta = 4.76, P = 0.011). The PPARgamma Pro12Ala Pro/Pro and resistin SNP-420 G/G genotypes were synergistically associated with plasma resistin, when adjusted for age, gender, and BMI, in the Japanese general population. |
Author | Kohara, Katsuhiko Makino, Hideichi Tabara, Yasuharu Kawamoto, Ryuichi Nishida, Wataru Yamada, Kazuya Miki, Tetsuro Onuma, Hiroshi Osawa, Haruhiko Ohashi, Jun Nakura, Jun Ochi, Masaaki |
Author_xml | – sequence: 1 givenname: Haruhiko surname: Osawa fullname: Osawa, Haruhiko email: harosawa@m.ehime-u.ac.jp organization: Department of Molecular and Genetic Medicine, Ehime University Graduate School of Medicine, Toon, Ehime, Japan. harosawa@m.ehime-u.ac.jp – sequence: 2 givenname: Yasuharu surname: Tabara fullname: Tabara, Yasuharu – sequence: 3 givenname: Ryuichi surname: Kawamoto fullname: Kawamoto, Ryuichi – sequence: 4 givenname: Jun surname: Ohashi fullname: Ohashi, Jun – sequence: 5 givenname: Masaaki surname: Ochi fullname: Ochi, Masaaki – sequence: 6 givenname: Hiroshi surname: Onuma fullname: Onuma, Hiroshi – sequence: 7 givenname: Wataru surname: Nishida fullname: Nishida, Wataru – sequence: 8 givenname: Kazuya surname: Yamada fullname: Yamada, Kazuya – sequence: 9 givenname: Jun surname: Nakura fullname: Nakura, Jun – sequence: 10 givenname: Tetsuro surname: Miki fullname: Miki, Tetsuro – sequence: 11 givenname: Hideichi surname: Makino fullname: Makino, Hideichi – sequence: 12 givenname: Katsuhiko surname: Kohara fullname: Kohara, Katsuhiko |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/19178525$$D View this record in MEDLINE/PubMed |
BookMark | eNpNkNtKw0AQhhdR7EFfQfbKu6R7yOZwWYpWpWjQ3odJMmlTNgd3UzTv4QObai0OM_w_zM_HMBNyXjc1EkI5c_lQs53Lpa8cIXzlCsZCl0lvsJ9nZHxanP_zIzKxdscYUyELLsmIRzwIlVBj8hXH89cNVBXQ2DRczPWPmQ1Doc6pQVvarqzp23PseILR5WxJN1g3Xd-ipWCQ2r5GszmkMtC6p2Btk5XQYU4_ym5LWw12wJ9IQ3dbpE_QQo0WDzQ0oGnbtHsNXdnUV-SiAG3x-qhTsr6_Wy8enNXL8nExXzmt8pSjIIwilQk_V0oGOfKiEKlgPkpWoJemMs1zEUaFLHyWSUARyDxDFcmA-57MmJyS219sa5r3PdouqUqbodbDXc3eJn7gs4BFh-DNMbhPK8yT1pQVmD75e6P8BhAFeWw |
ContentType | Journal Article |
DBID | CGR CUY CVF ECM EIF NPM 7X8 |
DOI | 10.1111/j.1365-2265.2008.03465.x |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1365-2265 |
ExternalDocumentID | 19178525 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | --- .3N .55 .GA .GJ .Y3 05W 08P 0R~ 10A 1OB 1OC 29B 31~ 33P 36B 3O- 3SF 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5GY 5HH 5LA 5RE 5VS 66C 6J9 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAESR AAEVG AAHQN AAIPD AAKAS AAMMB AAMNL AANHP AANLZ AAONW AAQQT AASGY AAXRX AAYCA AAZKR ABCQN ABCUV ABEML ABJNI ABPVW ABQWH ABXGK ACAHQ ACBWZ ACCZN ACGFO ACGFS ACGOF ACMXC ACPOU ACPRK ACRPL ACSCC ACXBN ACXQS ACYXJ ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADNMO ADOZA ADXAS ADZCM ADZMN AEFGJ AEGXH AEIGN AEIMD AENEX AEUYR AEYWJ AFBPY AFEBI AFFNX AFFPM AFGKR AFWVQ AFZJQ AGHNM AGQPQ AGXDD AGYGG AHBTC AHEFC AHMBA AIACR AIAGR AIDQK AIDYY AITYG AIURR ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN ALVPJ AMBMR AMYDB ASPBG ATUGU AVWKF AZBYB AZFZN AZVAB BAFTC BDRZF BFHJK BHBCM BMXJE BROTX BRXPI BY8 C45 CAG CGR COF CS3 CUY CVF D-6 D-7 D-E D-F DCZOG DPXWK DR2 DRFUL DRMAN DRSTM DU5 DUUFO EBS ECM EIF EJD EMOBN EX3 F00 F01 F04 F5P FEDTE FUBAC FZ0 G-S G.N GODZA H.X HF~ HGLYW HVGLF HZI HZ~ IHE IX1 J0M J5H K48 KBYEO LATKE LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES MEWTI MJL MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ NPM O66 O9- OIG OVD P2P P2W P2X P2Z P4B P4D PALCI PQQKQ Q.N Q11 QB0 R.K REN RIWAO RJQFR ROL RX1 SAMSI SUPJJ TEORI UB1 V8K W8V W99 WBKPD WHWMO WIH WIJ WIK WOHZO WOW WQJ WVDHM WXI WXSBR X7M XG1 YOC YUY ZGI ZXP ZZTAW ~IA ~WT 7X8 |
ID | FETCH-LOGICAL-p545-5a8995c26d5537de1ff2b206e30fe4bb3bdd289f3f60c3ae273dce59371643c03 |
ISSN | 1365-2265 |
IngestDate | Fri Sep 05 10:43:57 EDT 2025 Mon Jul 21 05:45:55 EDT 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 3 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-p545-5a8995c26d5537de1ff2b206e30fe4bb3bdd289f3f60c3ae273dce59371643c03 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
PMID | 19178525 |
PQID | 67607090 |
PQPubID | 23479 |
ParticipantIDs | proquest_miscellaneous_67607090 pubmed_primary_19178525 |
PublicationCentury | 2000 |
PublicationDate | 2009-Sep 20090901 |
PublicationDateYYYYMMDD | 2009-09-01 |
PublicationDate_xml | – month: 09 year: 2009 text: 2009-Sep |
PublicationDecade | 2000 |
PublicationPlace | England |
PublicationPlace_xml | – name: England |
PublicationTitle | Clinical endocrinology (Oxford) |
PublicationTitleAlternate | Clin Endocrinol (Oxf) |
PublicationYear | 2009 |
SSID | ssj0005807 |
Score | 1.9029813 |
Snippet | The Ala allele of the Pro12Ala polymorphism (rs1801282) of peroxisome proliferator-activated receptor gamma (PPARgamma) is protective against type 2 diabetes... |
SourceID | proquest pubmed |
SourceType | Aggregation Database Index Database |
StartPage | 341 |
SubjectTerms | Aged Asian Continental Ancestry Group - genetics Cross-Sectional Studies Female Genotype Humans Male Middle Aged Mutation, Missense Polymorphism, Single Nucleotide PPAR gamma - genetics Resistin - blood Resistin - genetics |
Title | PPARgamma Pro12Ala Pro/Pro and resistin SNP-420 G/G genotypes are synergistically associated with plasma resistin in the Japanese general population |
URI | https://www.ncbi.nlm.nih.gov/pubmed/19178525 https://www.proquest.com/docview/67607090 |
Volume | 71 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
journalDatabaseRights | – providerCode: PRVWIB databaseName: Wiley Online Library - Core collection (SURFmarket) issn: 1365-2265 databaseCode: DR2 dateStart: 19970101 customDbUrl: isFulltext: true eissn: 1365-2265 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0005807 providerName: Wiley-Blackwell |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1ba9swFBZZB2MvY_e1u-lh7CW4tS1bdh9D1yaUNgvBhbwZWZaXsNR265g1-x37QftpO8fyJR0pu0BihIyOjM9n6ejoOzqEfBAR2PCS-4YXc8dw_Dg2wE6ODC9iPveTSDoCA5zPx3x04ZzO3Fmv93ODtVSuon35fWtcyf9oFepArxgl-w-abYVCBZRBv3AFDcP1r3Q8mQymX8TlpUC-v2UPllUB5MFVE8dVgd8wfMLjieHYZn8IN4eYNjlD32vRR95Xscb4v-rAZrFcrvui1lhDTM_BwIYuWlk1M_IUpllMX4nS0LHVz9tcYJsW71ETeqnSOIMhSvvxq1NObzSxvnP0FuJbZcuOxHU5X3zNOrcC7olUs4UoyjncbecJaAFgq_y903W5kPNFK22OeaJ05El6y7nRsbea8bgi4dk6ncS-2lJXD-KetQFWtjEiM32u1t0zRSOt5tUyB4o33ezYMALGn8OTi7OzMDieBR_zKwPzluH-fp3E5R65b3ucYw6NT9PuADNXB-y3ndzmkm3t-u6lTmXyBI_Jo3qtQgcaeE9IT6VPyYPzmo3xjPxo8Ucb_GHhAP4U0EcbxNAafXR4MKQt9ihgj_6GPdphjyL2qMZeJwl-gD3aYI_W2KMd9p6T4OQ4OBoZdZYPIwfr3XAFrPhdafPYdZkXKytJ7Mg2uWJmopwoYlEc2_5hwhJuSiYUmNsxhg4yXOgzabIXZCfNUvWKUFM4eJqiNF3JHW5b2FIk3LNcYSXSlLvkffNmQxhEcWcMnjUri5B7HKa-Q3OXvNQvPMz1WS8hujN813b3_tj2NXnYIfgN2Vldl-otGKyr6F2FiV9WRJl6 |
linkProvider | Wiley-Blackwell |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=PPARgamma+Pro12Ala+Pro%2FPro+and+resistin+SNP-420+G%2FG+genotypes+are+synergistically+associated+with+plasma+resistin+in+the+Japanese+general+population&rft.jtitle=Clinical+endocrinology+%28Oxford%29&rft.au=Osawa%2C+Haruhiko&rft.au=Tabara%2C+Yasuharu&rft.au=Kawamoto%2C+Ryuichi&rft.au=Ohashi%2C+Jun&rft.date=2009-09-01&rft.issn=1365-2265&rft.eissn=1365-2265&rft.volume=71&rft.issue=3&rft.spage=341&rft_id=info:doi/10.1111%2Fj.1365-2265.2008.03465.x&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1365-2265&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1365-2265&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1365-2265&client=summon |